Using dexmedetomidine to improve outcomes for elderly ICU patients after surgery
Official title: Impact of Low-dose Dexmedetomidine on Outcomes of Elderly Admitted to ICU After Noncardiac Surgery: a Randomized Controlled Trial
Run by Peking University First Hospital · NCT04204798 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study is testing if giving low doses of dexmedetomidine at night can help older patients in the ICU after surgery live longer and feel better over the next year.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 65 Years and up |
| Sex | All |
| Enrollment | 1410 (estimated) |
| Sponsor | Peking University First Hospital Academic / other |
| Locations | 1 site (Beijing, Beijing) |
| Trial ID | NCT04204798 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are elderly individuals aged 65 and older who are admitted to the ICU after noncardiac surgery and expected to stay overnight.
✕Probably not a fit
Patients with pre-existing neurological conditions or severe bradycardia may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the effects of low-dose dexmedetomidine on long-term outcomes in elderly patients admitted to the ICU following noncardiac surgery. The study builds on previous findings that showed dexmedetomidine can enhance sleep quality and reduce delirium in ICU patients. Participants will receive either dexmedetomidine or a placebo during nighttime hours, with the aim of assessing its impact on one-year survival rates and overall quality of life. The trial is randomized and controlled, ensuring a robust methodology for evaluating the treatment's effectiveness.
Why it matters
Potential benefit: If successful, this treatment could significantly improve survival rates and quality of life for elderly patients recovering from surgery in the ICU.
How similar studies have gone: Previous studies have shown promising results with dexmedetomidine in similar patient populations, indicating a potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥65 years old; * Admitted to intensive care unit (ICU) after noncardiac surgery; * Expected to stay in ICU until the next morning. For those with endotracheal intubation, the expected duration of mechanical ventilation is \<24 hours; * Provide written informed consents. Exclusion Criteria: * Preoperative history of schizophrenia, epilepsy, Parkinsonism, or myasthenia gravis; * Inability to communicate in the preoperative period (coma, profound dementia, or language barrier); * Preoperative history of sleep apnea (previous diagnosis; or STOP-Bang score ≥3 with serum bicarbonate ≥ 28 mmol/L); * Known sick sinus syndrome, severe sinus bradycardia (\<50 beats per min \[bpm\]), or second degree or higher atrioventricular block without pacemaker; * Hypotension (systolic blood pressure \[SBP\] \<90 mmHg, mean arterial pressure \[MAP\] \<70 mmHg, or a decrease of SBP \>30% of baseline) or in a state of shock (vasopressors are required to maintain MAP ≥65 mmHg and serum lactate \>2 mmol/L); * Severe hepatic dysfunction (Child-Pugh class C), renal failure (requirement of renal replacement therapy), or expected survival \<24 hours; * Traumatic brain injury or neurosurgery; * Presence of delirium before surgery (assessed with Confusion Assessment Method \[CAM\]/CAM-ICU); * Undergoing treatment of dexmedetomidine or clonidine; * Other conditions that are considered unsuitable for study participation.
Where it's running
-
Peking University First Hospital
Beijing, Beijing, China Recruiting
Study contacts
- Principal investigator: Dong-Xin Wang, MD, PhD — Peking University First Hospital
- Study coordinator: Dong-Xin Wang, MD, PhD
- Email: wangdongxin@hotmail.com
- Phone: (86)10-83572784
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Dexmedetomidine to See if Delirium Drops After Hip Fracture Surgery
This observational study tests whether using dexmedetomidine around hip fracture surgery helps prevent postoperative delirium in adults 65 and older.
-
Esmolol vs Dexmedetomidine for opioid-sparing in laparoscopic gynecologic surgery
This study tests whether low-dose esmolol or dexmedetomidine, given during surgery, reduces opioid use and improves pain control after laparoscopic hysterectomy compared with placebo.
-
Dexmedetomidine with taVNS to see if PTSD after trauma surgery can be reduced
This study tests whether giving dexmedetomidine together with transcutaneous vagus nerve stimulation after emergency trauma surgery can lower the chances of developing PTSD.
-
Genomic changes of Klebsiella pneumoniae and Enterobacter cloacae in ICU patients over time
This study tests how the gut bacteria Klebsiella pneumoniae and Enterobacter cloacae evolve over time in adults in ICUs.
-
Dexmedetomidine vs magnesium as intraperitoneal add-ons to bupivacaine for laparoscopic gallbladder removal
This study tests whether adding dexmedetomidine or magnesium sulfate to bupivacaine injected inside the abdomen provides better pain relief after laparoscopic cholecystectomy for adults without serious health issues.
-
Dexmedetomidine vs magnesium with lidocaine for eye block during DCR surgery
This trial tests whether adding dexmedetomidine or magnesium sulfate to lidocaine for a preemptive peribulbar block can better manage blood pressure and heart rate in adults undergoing DCR surgery under general anesthesia.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.